| Follow Us: Facebook Twitter



46701 Commerce Center Dr
Plymouth, MI 48170

Esperion Therapeutics

Esperion Therapeutics discovers and develops novel therapies for the treatment of cardiovascular and metabolic diseases. The company is funded by top-tier venture capital investors, including Aisling Capital, Alta Partners, Arboretum Ventures, Asset Management Company and Domain Associates.

Related Content

The Re-Investors

With the successful exits of Esperion and Accuri, CEO's Roger Newton and Jen Baird could have taken the money and run. Instead, they're establishing new local ventures, reinvesting in Michigan's future, and helping to grow our entrepreneurial ecosystem. read on…

From Scratch: Denovo Sciences

What's the view at the bottom of Metro Detroit's entrepreneurial food chain? More diversity, less money. Case in point, Denovo Sciences. Its young partners are full of vim, vigor and a desire to "make change in human lives". What they could use is a little seed capital for their life science innovations. read on…
Signup for Email Alerts